SpringWorks Therapeutics Statistics
Total Valuation
RSG has a market cap or net worth of $72.19 billion. The enterprise value is $85.28 billion.
| Market Cap | 72.19B |
| Enterprise Value | 85.28B |
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Oct 2, 2025 |
Share Statistics
RSG has 312.22 million shares outstanding. The number of shares has decreased by -0.67% in one year.
| Current Share Class | 312.22M |
| Shares Outstanding | 312.22M |
| Shares Change (YoY) | -0.67% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.14% |
| Owned by Institutions (%) | 94.12% |
| Float | 311.59M |
Valuation Ratios
The trailing PE ratio is 34.20 and the forward PE ratio is 31.90. RSG's PEG ratio is 3.10.
| PE Ratio | 34.20 |
| Forward PE | 31.90 |
| PS Ratio | 4.43 |
| Forward PS | 4.12 |
| PB Ratio | 5.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 30.64 |
| P/OCF Ratio | 17.36 |
| PEG Ratio | 3.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.59, with an EV/FCF ratio of 36.20.
| EV / Earnings | 40.17 |
| EV / Sales | 5.21 |
| EV / EBITDA | 16.59 |
| EV / EBIT | 25.46 |
| EV / FCF | 36.20 |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 1.10.
| Current Ratio | 0.66 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 2.48 |
| Debt / FCF | 5.61 |
| Interest Coverage | 6.03 |
Financial Efficiency
Return on equity (ROE) is 18.41% and return on invested capital (ROIC) is 8.46%.
| Return on Equity (ROE) | 18.41% |
| Return on Assets (ROA) | 6.41% |
| Return on Invested Capital (ROIC) | 8.46% |
| Return on Capital Employed (ROCE) | 11.26% |
| Revenue Per Employee | $399,171 |
| Profits Per Employee | $51,780 |
| Employee Count | 41,000 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 90.89 |
Taxes
In the past 12 months, RSG has paid $441.00 million in taxes.
| Income Tax | 441.00M |
| Effective Tax Rate | 17.20% |
Stock Price Statistics
The stock price has increased by +18.98% in the last 52 weeks. The beta is 0.62, so RSG's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +18.98% |
| 50-Day Moving Average | 246.15 |
| 200-Day Moving Average | 228.71 |
| Relative Strength Index (RSI) | 34.73 |
| Average Volume (20 Days) | 1,483,813 |
Short Selling Information
The latest short interest is 2.49 million, so 0.80% of the outstanding shares have been sold short.
| Short Interest | 2.49M |
| Short Previous Month | 2.44M |
| Short % of Shares Out | 0.80% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 1.75 |
Income Statement
In the last 12 months, RSG had revenue of $16.37 billion and earned $2.12 billion in profits. Earnings per share was $6.76.
| Revenue | 16.37B |
| Gross Profit | 7.10B |
| Operating Income | 3.35B |
| Pretax Income | 2.34B |
| Net Income | 2.12B |
| EBITDA | 5.14B |
| EBIT | 3.35B |
| Earnings Per Share (EPS) | $6.76 |
Balance Sheet
The company has $122.00 million in cash and $13.22 billion in debt, giving a net cash position of -$13.09 billion or -$41.94 per share.
| Cash & Cash Equivalents | 122.00M |
| Total Debt | 13.22B |
| Net Cash | -13.09B |
| Net Cash Per Share | -$41.94 |
| Equity (Book Value) | 12.05B |
| Book Value Per Share | 38.62 |
| Working Capital | -1.23B |
Cash Flow
In the last 12 months, operating cash flow was $4.16 billion and capital expenditures -$1.80 billion, giving a free cash flow of $2.36 billion.
| Operating Cash Flow | 4.16B |
| Capital Expenditures | -1.80B |
| Free Cash Flow | 2.36B |
| FCF Per Share | $7.55 |
Margins
Gross margin is 43.38%, with operating and profit margins of 20.47% and 12.97%.
| Gross Margin | 43.38% |
| Operating Margin | 20.47% |
| Pretax Margin | 15.67% |
| Profit Margin | 12.97% |
| EBITDA Margin | 31.42% |
| EBIT Margin | 20.47% |
| FCF Margin | 14.40% |
Dividends & Yields
This stock pays an annual dividend of $2.50, which amounts to a dividend yield of 1.08%.
| Dividend Per Share | $2.50 |
| Dividend Yield | 1.08% |
| Dividend Growth (YoY) | 8.24% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 34.98% |
| Buyback Yield | 0.67% |
| Shareholder Yield | 1.75% |
| Earnings Yield | 2.94% |
| FCF Yield | 3.26% |
Analyst Forecast
The average price target for RSG is $255.95, which is 10.70% higher than the current price. The consensus rating is "Buy".
| Price Target | $255.95 |
| Price Target Difference | 10.70% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 5.86% |
| EPS Growth Forecast (5Y) | 8.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 19, 2007. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 19, 2007 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
RSG has an Altman Z-Score of 3.15 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 6 |